Jinliang Yang

4.9k total citations · 1 hit paper
109 papers, 2.7k citations indexed

About

Jinliang Yang is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Jinliang Yang has authored 109 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Molecular Biology, 30 papers in Oncology and 22 papers in Organic Chemistry. Recurrent topics in Jinliang Yang's work include Cancer therapeutics and mechanisms (12 papers), Synthesis and biological activity (11 papers) and Immunotherapy and Immune Responses (10 papers). Jinliang Yang is often cited by papers focused on Cancer therapeutics and mechanisms (12 papers), Synthesis and biological activity (11 papers) and Immunotherapy and Immune Responses (10 papers). Jinliang Yang collaborates with scholars based in China, United States and Canada. Jinliang Yang's co-authors include Yuxi Wang, Yuqin Yao, Yangping Wu, Lantu Gou, Xi Chen, Qiang Chen, Qinhuai Lai, Shijie Zhou, Ying Lu and Manyu Zhao and has published in prestigious journals such as Angewandte Chemie International Edition, Nature Communications and The Journal of Immunology.

In The Last Decade

Jinliang Yang

107 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Targeting fibrosis: mechanisms and clinical trials

2022 296 citations Ying Lu, Jinliang Yang et al. Signal Transduction and Targeted Therapy profile →

Peers

Jinliang Yang

ONCOL

IMMUN

Mark J. Suto United States

Min Xiao China

Yong‐Su Zhen China

Andrew M. Stern United States

Kaisheng Liu China

Xianzhang Bu China

Yingqi Zhang China

Dexin Kong China

Gyoonhee Han South Korea

Hemant K. Bid India

Mark J. Suto United States

Jinliang Yang

1.5k ×1.2

564 ×0.8

531 ×0.9

ONCOL

164 ×0.6

IMMUN

320 ×1.3

Citations per year, relative to Jinliang Yang Jinliang Yang (= 1×) peers Mark J. Suto

Countries citing papers authored by Jinliang Yang

Since Specialization

Citations

This map shows the geographic impact of Jinliang Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinliang Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinliang Yang more than expected).

Fields of papers citing papers by Jinliang Yang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jinliang Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinliang Yang. The network helps show where Jinliang Yang may publish in the future.

Co-authorship network of co-authors of Jinliang Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Jinliang Yang. A scholar is included among the top collaborators of Jinliang Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jinliang Yang. Jinliang Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Jingfang, Zihan Zhang, Xiangyu Luo, et al.. (2024). Sunlight stability enhancement of camphorquinone based photo-curing materials via [2 + 2] cycloaddition of pyrrole ketene. Progress in Organic Coatings. 187. 108198–108198. 3 indexed citations

Zhang, Jingyu, Qingjie Guo, Jiaojiao Chen, et al.. (2024). An electronic patient-reported outcome symptom monitor: the Chinese experience with rapid development of a ready-to-go symptom monitor. BMC Public Health. 24(1). 2989–2989. 1 indexed citations

Chi, Wenna, Sichen Liu, Lei Tao, et al.. (2024). MCT1-governed pyruvate metabolism is essential for antibody class-switch recombination through H3K27 acetylation. Nature Communications. 15(1). 163–163. 13 indexed citations

Wu, Yangping, Wenting Li, Xi Chen, et al.. (2023). DOG1 as a novel antibody-drug conjugate target for the treatment of multiple gastrointestinal tumors and liver metastasis. Frontiers in Immunology. 14. 1051506–1051506. 4 indexed citations

Liu, Shuang, et al.. (2021). Preparation and characterization of a high-afﬁnity monoclonal antibody against nerve growth factor. Protein Expression and Purification. 189. 105966–105966. 4 indexed citations

Yang, Tinghan, et al.. (2020). Intraoperative indocyanine green fluorescence angiography to prevent anastomotic leak after low anterior resection for rectal cancer: a meta‐analysis. ANZ Journal of Surgery. 90(11). 2193–2200. 26 indexed citations

Qin, Shugang, Ping Lin, Qun Wu, et al.. (2020). Small-Molecule Inhibitor of 8-Oxoguanine DNA Glycosylase 1 Regulates Inflammatory Responses during Pseudomonas aeruginosa Infection. The Journal of Immunology. 205(8). 2231–2242. 31 indexed citations

He, Lihui, Changcheng Li, Mei Kang, et al.. (2020). Molecular basis of the lipid-induced MucA-MucB dissociation in Pseudomonas aeruginosa. Communications Biology. 3(1). 418–418. 9 indexed citations

Arnst, Kinsie E., Yuxi Wang, Zi‐Ning Lei, et al.. (2019). Colchicine Binding Site Agent DJ95 Overcomes Drug Resistance and Exhibits Antitumor Efficacy. Molecular Pharmacology. 96(1). 73–89. 26 indexed citations

10.

Arnst, Kinsie E., Yuxi Wang, Dong‐Jin Hwang, et al.. (2017). A Potent, Metabolically Stable Tubulin Inhibitor Targets the Colchicine Binding Site and Overcomes Taxane Resistance. Cancer Research. 78(1). 265–277. 100 indexed citations

11.

Yin, Yuan, Chaoyong Shen, Xiaonan Yin, et al.. (2017). Preoperative imatinib mesylate (IM) for huge gastrointestinal stromal tumors (GIST). World Journal of Surgical Oncology. 15(1). 79–79. 16 indexed citations

12.

Zhang, Hang, Yuxi Wang, Yangping Wu, et al.. (2017). Therapeutic potential of an anti-HER2 single chain antibody–DM1 conjugates for the treatment of HER2-positive cancer. Signal Transduction and Targeted Therapy. 2(1). 17015–17015. 32 indexed citations

13.

Yao, Yuqin, Lin Yu, Xiaolan Su, et al.. (2015). Synthesis, characterization and targeting chemotherapy for ovarian cancer of trastuzumab-SN-38 conjugates. Journal of Controlled Release. 220(Pt A). 5–17. 34 indexed citations

14.

Wu, Yangping, Xi Chen, Xiaojun Ge, et al.. (2015). Isoliquiritigenin prevents the progression of psoriasis-like symptoms by inhibiting NF-κB and proinflammatory cytokines. Journal of Molecular Medicine. 94(2). 195–206. 39 indexed citations

15.

Lin, Yu, Yuxi Wang, Yuqin Yao, et al.. (2014). Eradication of Growth of HER2-Positive Ovarian Cancer With Trastuzumab-DM1, an Antibody-Cytotoxic Drug Conjugate in Mouse Xenograft Model. International Journal of Gynecological Cancer. 24(7). 1158–1164. 27 indexed citations

16.

Zhang, Chuanfu, Jiajun Cui, Qi Song, et al.. (2013). Bioinformatic analysis of the membrane cofactor protein CD46 and microRNA expression in hepatocellular carcinoma. Oncology Reports. 31(2). 557–564. 18 indexed citations

17.

Chen, Xi, Yangping Wu, Yangfu Jiang, et al.. (2012). Isoliquiritigenin inhibits the growth of multiple myeloma via blocking IL-6 signaling. Journal of Molecular Medicine. 90(11). 1311–1319. 30 indexed citations

18.

Tang, Xiaohai, Ping Xie, Yi Ding, et al.. (2010). Synthesis, characterization, and in vitro and in vivo evaluation of a novel pectin–adriamycin conjugate. Bioorganic & Medicinal Chemistry. 18(4). 1599–1609. 18 indexed citations

19.

Yang, Hanshuo, Chunting Wang, Rui Wang, et al.. (2009). Characterization of a novel rat gene RTAP2a, screened by cross-reactive SEREX, restrictedly expressed in testis. Journal of Bioscience and Bioengineering. 107(6). 589–595. 3 indexed citations

20.

Qin, Gang, et al.. (2007). Expression of Immunoglobulin M (IgM) in Multiple Epitheliogenic Malignant Tumor Tissue and Carcinoma Cell Lines. Zhongliu fangzhi yanjiu. 34(9). 686–689. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact